Press "Enter" to skip to content

New patent for Upsher Smith drug ZEMBRACE SYMTOUCH

0
Copyright © DrugPatentWatch. Originally published at New patent for Upsher Smith drug ZEMBRACE SYMTOUCH

Annual Drug Patent Expirations for ZEMBRACE+SYMTOUCH
Annual Drug Patent Expirations for ZEMBRACE+SYMTOUCH

Zembrace Symtouch is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.

ZEMBRACE SYMTOUCH drug price trends.

This drug has six patent family members in six countries.

The generic ingredient in ZEMBRACE SYMTOUCH is sumatriptan succinate. Two suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Upsher Smith drug ZEMBRACE SYMTOUCH
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions